HROW Shariah Compliance
Screening Methodology: AAOIFI
UNLOCK FOR FREE
Last Updated: March 04, 2026
Report Source: 2025 Annual Report
Harrow Inc. Stock Analysis HROW
United States Health Care Small Cap Report: Harrow, Inc. engages in the development, production, and sale of innovative medications. The company is headquartered in Nashville, Tennessee and currently employs 382 full-time employees. The company went IPO on 2013-02-08. The company offers a portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. The company owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. The company owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. The company owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE, BYQLOVI and others. Its product candidates include MELT-210, MELT-300 and MELT-400. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms.
Read More Harrow Inc (HROW) Chart
Harrow Inc (HROW) vs CBOE Volatility Index (VIX) Comparative Returns
Analysis of Harrow Inc (HROW) stock performance compared to the broader market (CBOE Volatility Index (VIX)) across multiple timeframes.
YTD Performance
- Harrow Inc (HROW) -28.1%
- CBOE Volatility Index (VIX) 7.42%
Harrow Inc Underperformed CBOE Volatility Index (VIX) by 35.52%
1Y Performance
- Harrow Inc (HROW) 51.07%
- CBOE Volatility Index (VIX) -3.02%
Harrow Inc Outperformed CBOE Volatility Index (VIX) by 54.09%
3Y Performance
- Harrow Inc (HROW) 102.94%
- CBOE Volatility Index (VIX) -19.46%
Harrow Inc Outperformed CBOE Volatility Index (VIX) by 122.40%
5Y Performance
- Harrow Inc (HROW) 361.13%
- CBOE Volatility Index (VIX) -51.47%
Harrow Inc Outperformed CBOE Volatility Index (VIX) by 412.60%
Key Statistics of Harrow Inc (HROW)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$35.20Volume
596.84KP/E Ratio (TTM)
-52 Week Range
Market Cap
1.52BAvg. Volume
1.06MDividend Yield
-Financial Metrics & Statements of Harrow Inc (HROW)
Super Investors Invested in Harrow Inc (HROW)
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
FAQ's for Harrow Inc (HROW)
- According to Musaffa’s Shariah screening methodology, Harrow Inc (HROW) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
Related Halal Stocks to Harrow Inc (HROW)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
